<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2020-12-04</date><key>BioC.key</key>
<document><id>26782073</id><passage><infon key="type">title</infon><offset>0</offset><text>Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer.</text><annotation id="0"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="10" length="30"/><text>junctional adhesion molecule-2</text></annotation></passage><passage><infon key="type">abstract</infon><offset>119</offset><text>The junctional adhesion molecule (JAMs) family belongs to the immunoglobulin subfamily involved in the formation of tight junctions (TJ) in both endothelial and epithelial cells. Aberrant expression of JAM-2 is associated with cancer progression but little work has been carried out in discovering how this affects changes in cell behaviour. The present study aimed to examine the expression of JAM-2 in human colon cancer specimens and cell lines and its role in the development of colon cancer. JAM-2 expression in human colon cancer specimens (normal, n=75; cancer, n=94) and cell lines was analysed using quantitative real-time PCR and conventional RT-PCR. Colon cancer cells were stably transfected with a mammalian expression vector to overexpress JAM-2-Flag. The effect on growth, adhesion and migration following overexpression of JAM-2 was then investigated using in vitro models. TJ function was assessed using a trans-epithelial resistance assay (TER, with an EVOM voltammeter). JAM-2 was lowly expressed in colon cancer cells such as RKO, HT115. JAM-2 overexpression in RKO cells (RKO-JAM-2) and HT115 cells (HT115-JAM-2) showed retarded adhesion (P&lt;0.05). An in vivo tumour model showed that RKO-JAM-2 had significantly reduced growth (P&lt;0.05), invasion (P&lt;0.05) and migration (P&lt;0.05) as well as in HT115-JAM-2, except on proliferation and migration. Expression of JAM-2 resulted in a significant increase in TER and decrease in permeability of polarized monolayers (P&lt;0.05). Further analysis of JAM-2 transcript levels against clinical aspects demonstrated that the decreasing JAM-2 expression correlated to disease progression, metastasis and poor survival. Taken together, JAM-2 may function as a putative tumour suppressor in the progression and metastasis of colorectal cancer.</text><annotation id="1"><infon key="code">222</infon><infon key="NCBI Gene identifier">58494</infon><infon key="type">Gene</infon><location offset="123" length="28"/><text>junctional adhesion molecule</text></annotation><annotation id="2"><infon key="code">222</infon><infon key="NCBI Gene identifier">58494</infon><infon key="type">Gene</infon><location offset="153" length="3"/><text>JAM</text></annotation><annotation id="3"><infon key="code">333</infon><infon key="NCBI Gene identifier">3514</infon><infon key="type">Gene</infon><location offset="181" length="14"/><text>immunoglobulin</text></annotation><annotation id="4"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="321" length="5"/><text>JAM-2</text></annotation><annotation id="5"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="514" length="5"/><text>JAM-2</text></annotation><annotation id="6"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="616" length="5"/><text>JAM-2</text></annotation><annotation id="7"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="873" length="5"/><text>JAM-2</text></annotation><annotation id="8"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="958" length="5"/><text>JAM-2</text></annotation><annotation id="9"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1109" length="5"/><text>JAM-2</text></annotation><annotation id="10"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1177" length="5"/><text>JAM-2</text></annotation><annotation id="11"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1216" length="5"/><text>JAM-2</text></annotation><annotation id="12"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1246" length="5"/><text>JAM-2</text></annotation><annotation id="13"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1328" length="5"/><text>JAM-2</text></annotation><annotation id="14"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1438" length="5"/><text>JAM-2</text></annotation><annotation id="15"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1498" length="5"/><text>JAM-2</text></annotation><annotation id="16"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1629" length="5"/><text>JAM-2</text></annotation><annotation id="17"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1711" length="5"/><text>JAM-2</text></annotation><annotation id="18"><infon key="NCBI Gene identifier">58494</infon><infon key="type">GENERIF</infon><location offset="1809" length="5"/><text>JAM-2</text></annotation></passage></document>
</collection>
